The carcinoid tumor, syndrome and spectrum. A review of the literature.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003533:Cyproheptadine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004837:Epinephrine; D004873:Ergolines / Q000627:therapeutic use; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D010649:Phenylalanine / Q000627:therapeutic use; D011736:Pyridoxine / Q000037:antagonists & inhibitors; D011859:Radiography; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists; D012882:Skin Tests; D014364:Tryptophan
D000970:Antineoplastic Agents; D004873:Ergolines; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D010649:Phenylalanine; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D006899:Mixed Function Oxygenases; D011736:Pyridoxine; D004837:Epinephrine